top of page
A Game-Changer in Heart Health: What the Approval of Lipfendra (Enlicitide) Means for Urban India
On July 16, 2026, the U.S. FDA marked a significant milestone in cardiovascular medicine by approving Lipfendra (enlicitide). It is the world’s first once-daily oral PCSK9 inhibitor pill.
Mathew Peedikayil
Jul 303 min read
bottom of page